- Home
- CELZ vs CPHI Comparison
CELZ vs CPHI Comparison
Compare CELZ & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- CPHI
- Stock Information
- Founded
- CELZ 1998
- CPHI N/A
- Country
- CELZ United States
- CPHI China
- Employees
- CELZ N/A
- CPHI N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- CPHI Health Care
- Exchange
- CELZ Nasdaq
- CPHI Nasdaq
- Market Cap
- CELZ 4.7M
- CPHI 4.2M
- IPO Year
- CELZ N/A
- CPHI N/A
- Fundamental
- Price
- CELZ $2.55
- CPHI $0.19
- Analyst Decision
- CELZ
- CPHI
- Analyst Count
- CELZ 0
- CPHI 0
- Target Price
- CELZ N/A
- CPHI N/A
- AVG Volume (30 Days)
- CELZ 62.2K
- CPHI 380.9K
- Earning Date
- CELZ 11-08-2024
- CPHI 11-13-2024
- Dividend Yield
- CELZ N/A
- CPHI N/A
- EPS Growth
- CELZ N/A
- CPHI N/A
- EPS
- CELZ N/A
- CPHI N/A
- Revenue
- CELZ $11,000.00
- CPHI $5,544,620.00
- Revenue This Year
- CELZ N/A
- CPHI N/A
- Revenue Next Year
- CELZ N/A
- CPHI N/A
- P/E Ratio
- CELZ N/A
- CPHI N/A
- Revenue Growth
- CELZ N/A
- CPHI N/A
- 52 Week Low
- CELZ $2.41
- CPHI $0.17
- 52 Week High
- CELZ $10.28
- CPHI $1.15
- Technical
- Relative Strength Index (RSI)
- CELZ 36.30
- CPHI 36.69
- Support Level
- CELZ $2.41
- CPHI $0.18
- Resistance Level
- CELZ $2.67
- CPHI $0.21
- Average True Range (ATR)
- CELZ 0.29
- CPHI 0.02
- MACD
- CELZ -0.05
- CPHI -0.00
- Stochastic Oscillator
- CELZ 11.21
- CPHI 16.25
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.